Last quarter (Q4 2024), Telo Genomics Corp's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Telo Genomics Corp's net income was $-552.76K. See Telo Genomics Corp’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ 2.60M	$ 2.72M	$ 2.82M	$ 2.11M	$ 1.26M	$ 1.31M
Operating Income	$ -2.60M	$ -2.72M	$ -2.82M	$ -2.11M	$ -1.26M	$ -1.31M
Net Non Operating Interest Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ 26.54K
Other Income Expense	$ -10.00K	$ -10.00K	$ ―	$ ―	$ 187.23K	$ 95.70K
Pretax Income	$ -2.59M	$ -2.71M	$ -2.82M	$ -2.11M	$ -1.07M	$ -1.24M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -2.59M	$ -2.71M	$ -2.82M	$ -2.11M	$ -1.07M	$ -1.24M
Basic EPS	$ -0.04	$ -0.04	$ -0.05	$ -0.04	$ -0.02	$ -0.04
Diluted EPS	$ -0.04	$ -0.04	$ -0.05	$ -0.04	$ -0.02	$ -0.04
Basic Average Shares	$ 288.79M	$ 71.38M	$ 60.15M	$ 58.66M	$ 46.89M	$ 29.93M
Diluted Average Shares	$ 288.79M	$ 71.38M	$ 60.15M	$ 58.66M	$ 46.89M	$ 29.93M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 2.60M	$ 2.72M	$ 2.82M	$ 2.11M	$ -1.26M	$ -1.31M
Net Income From Continuing And Discontinued Operation	$ -2.59M	$ -2.71M	$ -2.82M	$ -2.11M	$ -1.07M	$ -1.24M
Normalized Income	$ -2.05M	$ -1.99M	$ -2.07M	$ -1.55M	$ -973.66K	$ -1.01M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -2.59M	$ -2.71M	$ -2.82M	$ -2.11M	$ -1.07M	$ -1.22M
EBITDA	$ -2.56M	$ -2.67M	$ -2.79M	$ -2.05M	$ -1.01M	$ -1.15M

Currency in USD

Telo Genomics Corp Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing